- We emerged from Riverstone’s post-results briefing feeling upbeat. Its growth prospects remain intact, premised on its differentiated strategy that should keep any near-term challenges within the generic product segment at bay.
- - Read this at SGinvestors.io -
Key operating metrics.
- Riverstone’s cleanroom gloves (CG) ASP contracted to US$90/1k pieces, from US$94/1k pieces. For 4Q24, its healthcare gloves (HG) ASP declined to US$27.40/1k pieces vs US$28.50/1k pieces in 3Q24.
- - Read this at SGinvestors.io -
- We expect the cleanroom gloves price change to be flattish-to-mild increase in 1Q25, given the bulk price has already been locked in periodically. healthcare gloves prices are expected to remain range-bound in the US$27-28 range as well due to Riverstone’s product mix being tilted towards the generic segment (driven by trade diversions).
- Both cleanroom gloves and healthcare gloves sales volumes contracted by 6% and 1% q-o-q due to seasonality and shipment delays. Management expects the sales growth momentum for cleanroom gloves to continue in the coming quarters, underpinned by sustained order replenishments from tech customers and the increasing adoption of cleanroom gloves by the pharmaceutical industry.
Competitive landscape.
- Read more at SGinvestors.io.
Singapore Research RHB Securities Research | https://www.rhbgroup.com/ 2025-02-25
Previous report by RHB:
2025-02-24 Riverstone - Chalks A Solid Close To FY24; Maintain BUY..
Price targets by other brokers at Riverstone Target Prices.
Listing of research reports at Riverstone Analyst Reports.
Relevant links:
Riverstone Share Price History,
Riverstone Announcements,
Riverstone Dividend Payout Dates & Corporate Actions,
Riverstone News
